ATE526313T1 - Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitor - Google Patents
Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitorInfo
- Publication number
- ATE526313T1 ATE526313T1 AT08721356T AT08721356T ATE526313T1 AT E526313 T1 ATE526313 T1 AT E526313T1 AT 08721356 T AT08721356 T AT 08721356T AT 08721356 T AT08721356 T AT 08721356T AT E526313 T1 ATE526313 T1 AT E526313T1
- Authority
- AT
- Austria
- Prior art keywords
- sphingosine compound
- production
- sphingomyelinase inhibitor
- compound
- sphingomyelinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007060950 | 2007-03-09 | ||
PCT/JP2008/053936 WO2008111450A1 (ja) | 2007-03-09 | 2008-03-05 | スフィンゴシン化合物、その製造方法及びスフィンゴミエリナーゼ阻害剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE526313T1 true ATE526313T1 (de) | 2011-10-15 |
Family
ID=39759393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08721356T ATE526313T1 (de) | 2007-03-09 | 2008-03-05 | Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitor |
Country Status (6)
Country | Link |
---|---|
US (1) | US8093395B2 (de) |
EP (1) | EP2133335B9 (de) |
JP (1) | JP5178707B2 (de) |
AT (1) | ATE526313T1 (de) |
TW (1) | TWI391377B (de) |
WO (1) | WO2008111450A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9708354B2 (en) | 2013-03-15 | 2017-07-18 | Cerenis Therapeutics Holding Sa | Methods for the synthesis of sphingomyelins and dihydrosphingomyelins |
MX2015012877A (es) * | 2013-03-15 | 2016-02-03 | Cerenis Therapeutics Holding Sa | Metodos para la sintesis de esfingomielinas y dihidroesfingomielinas. |
BR102013031043B1 (pt) * | 2013-12-02 | 2018-03-13 | Fundação Butantan | Uso de compostos químicos capazes de inibir a ação tóxica das esfingomielinases d do veneno de aranhas loxosceles e composição farmacêutica compreendendo os referidos compostos |
WO2022138757A1 (ja) * | 2020-12-24 | 2022-06-30 | デンカ株式会社 | Dna構築物、ベクター、細菌及びポリペプチドを製造する方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000086601A (ja) | 1998-09-04 | 2000-03-28 | Otsuka Pharmaceut Co Ltd | セラミド誘導体 |
AU1548101A (en) * | 1999-11-24 | 2001-06-04 | Sagami Chemical Research Center | Sphingosine derivatives |
JP2001213858A (ja) * | 1999-11-24 | 2001-08-07 | Sagami Chem Res Center | スフィンゴシン誘導体 |
JP4165198B2 (ja) | 2002-11-28 | 2008-10-15 | ダイソー株式会社 | スフィンゴミエリン類縁体およびその製法 |
JP4182910B2 (ja) | 2004-03-30 | 2008-11-19 | ダイソー株式会社 | スフィンゴミエリン類縁体とその製造法 |
-
2008
- 2008-03-05 JP JP2009503989A patent/JP5178707B2/ja not_active Expired - Fee Related
- 2008-03-05 AT AT08721356T patent/ATE526313T1/de not_active IP Right Cessation
- 2008-03-05 WO PCT/JP2008/053936 patent/WO2008111450A1/ja active Application Filing
- 2008-03-05 EP EP08721356A patent/EP2133335B9/de not_active Not-in-force
- 2008-03-05 US US12/530,311 patent/US8093395B2/en not_active Expired - Fee Related
- 2008-03-07 TW TW097108119A patent/TWI391377B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8093395B2 (en) | 2012-01-10 |
WO2008111450A1 (ja) | 2008-09-18 |
EP2133335B1 (de) | 2011-09-28 |
US20100099881A1 (en) | 2010-04-22 |
TW200900381A (en) | 2009-01-01 |
EP2133335A4 (de) | 2010-12-15 |
JPWO2008111450A1 (ja) | 2010-06-24 |
TWI391377B (zh) | 2013-04-01 |
JP5178707B2 (ja) | 2013-04-10 |
EP2133335B9 (de) | 2012-03-21 |
EP2133335A1 (de) | 2009-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE550334T1 (de) | N-pyridylpiperidinverbindung, verfahren zu ihrer herstellung und schädlingsbekämpfungsmittel | |
WO2008126933A3 (en) | Process for producing pesticidal benzamide compounds | |
MX363956B (es) | Agente de control de plagas. | |
WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規1,2,3,4-テトラヒドロキノキサリン誘導体 | |
MY152535A (en) | Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors | |
EA017861B9 (ru) | Способ получения 4-оксохинолинового соединения | |
WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
MX2009008772A (es) | Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion. | |
NZ596653A (en) | Total synthesis of salinosporamide a and analogs thereof | |
ATE526313T1 (de) | Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitor | |
DE602005010369D1 (de) | 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren | |
WO2008003620A3 (de) | Elektrochemische herstellung sterisch gehinderter amine | |
BRPI0921059A2 (pt) | derivados de bifenilacetamida | |
AR077472A1 (es) | Inhibidores de transportador de glicina | |
IN2012DN00361A (de) | ||
WO2008030838A3 (en) | Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity | |
DE602004025935D1 (de) | Histondeacetylaseinhibitor und verfahren zu dessen herstellung | |
ATE525386T1 (de) | 3'-ethynylcytidinderivat | |
ATE473989T1 (de) | Eine phosphorylcholingruppe enthaltende verbindung, und verfahren zu ihrer herstellung | |
EA201070486A1 (ru) | Усовершенствованный способ получения 2-(замещенный фенил)-2-гидроксиэтилкарбаматов | |
EA201000084A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
ATE444323T1 (de) | Neuartige epoxidverbindungen und verfahren zu ihrer herstellung | |
WO2008006236A3 (en) | Benzimidazoles as cooling compounds | |
ATE557063T1 (de) | Thermoplastische polymerzusammensetzung und herstellungsverfahren dafür |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |